Litcius/Paper detail

Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway

Fangfang Wang, Jingcao Huang, Tingting Guo, Yuhuan Zheng, Li Zhang, Dan Zhang, Fujue Wang, Duolan Naren, Yushan Cui, Xiaoyan Liu, Ying Qu, Hongmei Luo, Yang Yan, Haichen Wei, Yong Guo

2021Biochemical Pharmacology21 citationsDOI

Topics & Concepts

HomoharringtonineMyeloid leukemiaCancer researchMedicineMCL1Protein kinase BLeukemiaFms-Like Tyrosine Kinase 3PharmacologyApoptosisImmunologyBiologyDownregulation and upregulationGeneBiochemistryMutationAcute Myeloid Leukemia ResearchProtein Degradation and InhibitorsHistone Deacetylase Inhibitors Research
Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway | Litcius